---
layout: entry
title: "Clinical Research Slows as COVID-19 Surges"
link: "https://doi.org/10.1158/2159-8290.CD-NB2020-021"
author:
- American Association for Cancer, Research

summary:
- "the COVID-19 pandemic worsens, the clinical cancer community is grappling with how to continue providing access to experimental but potentially lifesaving therapies. To that end, cancer centers are making changes to their clinical trial programs, while pharmaceutical companies are deciding how-or whether-trials should continue. Pharma companies are considering how-and whether to continue their clinical trials. Cancer centers are changing their trial programs and making changes. Until now, the cancer community has grappled with the need to provide access to lifesaving treatments in the 'COVID epidemic worsened. The clinical cancer communities are grappling."

original:
- "As the COVID-19 pandemic worsens, the clinical cancer community is grappling with how to continue providing access to experimental but potentially lifesaving therapies while keeping immunocompromised patients safe. To that end, cancer centers are making changes to their clinical trial programs, while pharmaceutical companies are deciding how-or whether-trials should continue."
---

